Critical Appraisal of the Role of Ruxolitinib in Myeloproliferative Neoplasm-Associated Myelofibrosis
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s31916
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Informa UK Limited